High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A

Infection and Immunity

Volumn 69, Issue 1, 2001, Pages 570-574

  Pless, D D ^a   Torres, E R ^a   Reinke, E K ^a   Bavari, S ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; EPITOPE MAPPING; HYBRIDOMA; KINETICS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BINDING SITES; BIOSENSING TECHNIQUES; BOTULINUM TOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; MICE; MICE, INBRED BALB C; VACCINATION;

EID: 0035173621     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.1.570-574.2001     Document Type: Article

References (19)

1. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries
2. Identifying the principal protective antigenic determinants of type A botulinum neurotoxin
3. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP25
4. Identification and characterization of a neutralizing monoclonal antibody against botulinum hen rotoxin, serotype F, following vaccination with active toxin
5. Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli
6. Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum
7. Induction of an immune response by oral administration of recombinant botulinum toxin
8. Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies
9. Sequence homology and structural analysis of the clostridial neurotoxins
10. Unraveling the structures and modes of action of bacterial toxins
11. Crystal structure of botulinum neurotoxin type A and implications for toxicity
12. Mechanism of action of tetanus and botulinum neurotoxins
13. Botulinum toxin: The story of its development for the treatment of human disease
14. Human immune response to botulinum pentavalent (AB-CDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay
15. The origin, structural and pharmacological activity of botulinum toxin
16. The study of clostridial and related toxins. The search for unique mechanisms and common denominators
17. Tetanus and botulism neurotoxins: A novel group of zine-endopeptidases
18. C of tetanus neurotoxin
19. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay